Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

ClinicalTrials.gov ID: NCT00236093

Public ClinicalTrials.gov record NCT00236093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4-week, Open-Label Extension Study of ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to monitor the safety (adverse event data) of longer-term use of ACTIQ (Oral Transmucosal Fentanyl Citrate \[OTFC\]) treatment in children with pain associated with cancer, sickle cell disease, or severe burns and breakthrough pain (BTP) who are receiving around the clock (ATC) opioid therapy.

Study identification

NCT ID
NCT00236093
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cephalon
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years to 15 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2006 (Type not available)
Primary completion
Dec 2006 (Actual)
Completion
Not listed
Last update posted
May 9, 2014

Started 2006

United States locations

U.S. sites
26
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Children's Hospital of Arkansas Little Rock Arkansas 72202 —
Childrens Hospital of Orange Orange California 92868 —
Lucille Packard Childresns Hospital Palo Alto California 94304 —
Connecticut Childrens Medical Hartford Connecticut 06106 —
Childrens National Medical Center Washington D.C. District of Columbia 20010 —
Nemours Childrens Clinc Jacksonville Florida 32207 —
St. Joseph's Childrens Hopsital Tampa Florida 33660 —
Kapi'olani Medical Center Honolulu Hawaii 96826 —
University Hospitals of Iowa Iowa City Iowa 52242 —
David Center for Childrens Pain and Palliative Care Hackensack New Jersey 07601 —
Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
University of New Mexico Albuquerque New Mexico 87131 —
Scottish Rite Children's Medical Center Syracuse New York 13210 —
SUNY Upstate Medical University Syracuse New York 13210 —
Children's Hospital at Montefiore The Bronx New York 10467 —
Duke University Hospital Durham North Carolina 27710 —
Akron Children's Hospital Akron Ohio 44308 —
Tod Childrens Hospital Youngstown Ohio 44501 —
Milton S Hershey Medical Center Hershey Pennsylvania 17033 —
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Children's Cancer and Blood Disorders Center San Antonio Texas 78207 —
Methodist Hospital San Antonio Texas 78229 —
Sacred Heart Medical Center Spokane Washington 99204 —
West Virginia Univeristy Morgantown West Virginia 99204 —
Childrens Hospital of Wisconsin Milwaukee Wisconsin 53201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00236093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2014 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00236093 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →